Suxiao Jiuxin pill for stabilizing vulnerable plaques in heart attack
Part of Heart & circulation clinical trials.
This trial is testing whether a traditional Chinese medicine called Suxiao Jiuxin Pill, when added to standard emergency heart attack treatment (coronary angiography and stenting), can help make the fatty plaques inside your heart arteries more stable and reduce the risk of further heart problems. It's a phase 4 study, meaning the medicine is already used in practice, and this trial aims to gather more evidence on its benefits for people having a heart attack.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have been diagnosed with a heart attack (acute myocardial infarction) and be admitted through the emergency department.
- You must be scheduled for emergency coronary angiography (an X-ray of your heart's arteries) and possible stent placement (PCI) to reopen blocked vessels.
- You must not be in cardiogenic shock (heart failure causing very low blood pressure) or have life-threatening heart rhythm problems.
- You must not have severe organ failure (like advanced liver, kidney, or heart failure), recent brain bleeding, or a major tumor that limits life expectancy.
- You must not be allergic to the study drug components, and not be pregnant or breastfeeding. You also cannot have taken other similar traditional Chinese medicines recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a Chinese herbal medicine called Qishenyiqi to see if it helps the heart recover and remodel (repair its shape) after a heart attack. It is for people whose heart is still weak (pumping less than 40%) and who have heart failure symptoms.
This trial tests if a Chinese herbal pill called Qishenyiqi can help people with chest pain caused by tiny heart blood vessels that are too tight. It may be an option if standard tests show your heart vessels are mostly clear but your blood flow is reduced.
This trial adds a Chinese medicine (Shexiang Baoxin Pill) to standard care for people having a heart attack, to see if it improves recovery when taken alongside the usual artery-opening procedure. It may help speed up heart recovery and reduce further damage.
This study tests a Chinese herbal medicine called Xuesaitong soft capsules for people who recently had a heart attack or unstable angina and had a stent placed. The goal is to see if taking these capsules helps improve heart health after the procedure.
This study tests whether a traditional Chinese medicine called Guanxinning Tablet can help improve blood flow in the tiny vessels of the heart after a heart attack treated with a stent. It may help your heart recover better and reduce future heart problems.
This trial tests if adding the herbal injection Shuxuening to standard clot-busting treatment improves recovery for people having an ischemic stroke. It is for adults within 6 hours of symptom onset who are already receiving a clot-dissolving medication.
Hear when a new Acute Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.